A 3D-QSAR analysis of prolyl endopeptidase inhibitors

Quantitative Structure-Activity Relationships

Volumn 18, Issue 5, 1999, Pages 456-463

  Fehér, Miklós ^a,c   Kánai, Károly ^a   Hermecz, István ^a   Lopata, Antal ^b   Novák, István ^b  

^a Chinoin Pharmaceutical and Chemical Works Ltd   (Hungary)

^b CheMicro Ltd   (Hungary)

^c Nanodesign Inc   (Canada)

Author keywords

3D QSAR; CoMFA; Molecular modelling; Prolyl endopeptidase inhibitors

Indexed keywords

COMPUTATIONAL CHEMISTRY; CONFORMATIONS; ENZYMES;

3D-QSAR; ANALYSIS MODELS; BEND FORM; COMPARATIVE MOLECULAR FIELD ANALYSIS; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; QSAR ANALYSIS; SYNTHESISED; TEMPLATE STRUCTURES; VALIDATION SETS;

MOLECULES;

PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR;

ARTICLE; COMPARATIVE STUDY; CONFORMATION; CRYSTALLIZATION; ENERGY; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 18144432674     PISSN: 09318771     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3838(199911)18:5<456::AID-QSAR456>3.0.CO;2-N     Document Type: Article

References (28)

1. Wilk, S., Prolyl Endopeptidase, Life Sciences 33, 2149-2157 (1983),
2. Goossens, F., De Meester, B., Vanhoof, G. and Scharpé, S., Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and Body Fluids, Eur. J Clin. Chem. Clin. Biochem. 34, 17-22 (1996).
3. Soeda, S., Yamakawa, N., Ohyama, M., Shimeno, H. and Nagamatsu, A., An Inhibitor of Proline Endopeptidase: Purification from Rat Brain and Characterization, Chem. Pharm. Bull. 33, 2445-2451 (1985).
4. O'Leary, R.M. and O'Connor, B., Identification and localisation of a synaptosomal membrane prolyl endopeptidase from bovine brain, Eur. J Biochem. 227, 277-283 (1995).
5. Yoshimoto, T., Kawahara, K., Matsubara, F., Kado, K. and Tsuru, D., Comparison of Inhibitory Effects of Prolinal-Containing Peptide Derivatives on Prolyl Endopeptidases from Bovine Brain and Flavobacterium, J Biochem. 98, 975-979 (1985).
6. Fülöp, V., Böcskei, Zs. and Polgár, L., Prolyl Oligopeptidase: An Unusual β-Propeller Domain Regulates Proteolysis, Cell 94, 161-170 (1998).
7. Toide, K., Fujiwara, T., Iwamoto, Y., Shinoda, M., Okamiya, K. and Kato, T., Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 355-362 (1996).
8. Griffiths, E.C., Baris, C., Visser, T.J. and Klootwijk, W., Thyrotropin-releasing hormone inactivation by human post-mortem brain, Regul. Pept. 10, 145-155 (1985).
9. Ishiura, S., Tsukahara, T., Tabira, T., Shimizu, T., Arahata, K. and Sugita, H., Identification of a putative amyloid A4-generating enzyme as a prolyl endopeptidase, FEBS Lett. 260, 131-134 (1990).
10. Fukunari, A., Kato, A., Sakai, Y., Yoshimoto, T., Ishiura, S., Suzuki, K. and Nakajima, T., Colocalization of prolyl endopeptidase and amyloid β-peptide in brains of senescence-accelerated mouse, Neurosci. Lett. 176, 201-204 (1994).
11. Aoyagi, T., Wada, T., Nagai, M., Kojima, F., Harada, S., Takeuchi, T., Takahashi, H., Hirokawa, K. and Tsumita, T., Deficiency of kallikrein-like enzyme activities in cerebral tissues of patients with Alzheimer's disease, Experientia 46, 94-97 (1990).
12. Gibson, A.M., Edwardson, J.A. and McDermott, J.R., Post mortem levels of some brain peptidase in Alzheimer's disease: reduction in proline endopeptidase activity in cerebral cortex, Neurosci. Res. Commun. 9, 73-81 (1991).
13. Saito, M., Hashimoto, M., Kawaguchi, N., Shibata, H., Fukami, H., Tanaka, T. and Higuchi, N., Synthesis and Inhibitory Activity of Acyl-Peptidyl-Pyrrolidine Derivatives Toward Post-Proline Cleaving Enzyme: A Study of Subsite Specificity, J Enzyme Inhibition 5, 51-57 (1991).
14. Tanaka, Y., Niwa, S., Nishioka, H., Yamanaka, T., Torizuka, M., Yoshinaga, K., Kobayashi, N., Ikeda, Y. and Arai, H., New Potent Prolyl Endopeptidase Inhibitors: Synthesis and Structure-Activity Relationships of Indan and Tetralin Derivatives and Their Analogues, J. Med. Chem. 37, 2071-2078 (1994).
15. Portevin, B., Benoist, A., Rémond, G., Hervé, Y, Vincent, M., Lepagnol, J. and De Nanteuil, G., New Prolyl Endopeptidase Inhibitors. In Vitro and in Vivo Activities of Azabicyclo[2.2.2]octane, Azabicyclo[2.2.1]heptane, and Perhydroindole Derivatives, J. Med. Chem. 39, 2379-2391 (1996) and references cited therein.
16. De Nanteuil, G., Portevin, B. and Lepagnol, J., Prolyl endopeptidase inhibitors: a new class of memory enhancing drugs, Drugs of the Future 23, 167-179 (1998).
17. Tsuru, D., Yoshimoto, T., Koriyama, N. and Furukawa, S., Thiazolidine Derivatives as Potent Inhibitors Specific for Prolyl Endopeptidase, J. Biochem. 104, 580-586 (1988).
18. Yoshimoto, T., Tsuru, D., Yamamoto, N., Ikezawa, R. and Furukawa, S., Structure Activity Relationship of Inhibitors Specific for Prolyl Endopeptidase, Agric. Biol. Chem. 55, 37-43 (1991).
19. Martin, Y.C., Kim, K.H. and Lin, C.T., Comparative Molecular Field Analysis: CoMFA, Adv. in. Quant. Structure-Property Relationships 1, 1-52 (1996).
20. Langer, T. and Wermuth, C.G., Inhibitors of prolyl endopeptidase: Characterization of the pharmacophoric pattern using conformational analysis and 3D-QSAR, J Comp.-Aided Mol. Design 7, 253-262 (1993).
21. Kinai, K., Erdõ, S., Szappanos, A., Bence, J., Hermecz, I., Szvoboda, Gyné, Bátori, S., Héja, G., Balogh, M., Horváth, Á, Sipos, J., Bartáné Bodor, V., Párkányi, Zs., Lakics, V. and Molnár, P., PCT Int. Appl. WO 07116 (1997); CA 126, 238661m (1997).
22. Kinai, K., Erdõ, S., Szappanos, A., Bence, J., Hermecz, I., Szvoboda, Gyné, Bátori, S., Héja, G., Balogh, M., Horváth, Á, Sipos, J., Bartáné Bodor, V., Párkányi, Zs., Lakics, V. and Molnár, P., PCT Int. Appl. WO 07116 (1997); CA 126, 238661m (1997).
23. Kánai, K., Erdo, S., Susán, E., Fehér, M., Sipos, J., Podányi, B., Szappanos, A. and Hermecz, L, Prolyl Endopeptidase Inhibitors: N-Acyl Derivatives of L-Thioproline-Pyrrolidine, Bioorg. Med. Chem. Letters 7, 1701-1704 (1997).
24. Sybyl, version 6.4, Tripos, Inc., St. Louis, MO.
25. Fehér, M., Kánai, K., Podányi, B. and Hermecz, I., Conformational Analysis of two Inhibitors of Prolyl-endopeptidase: Comparison of 4-Phenyl-butyryl-and Octanoyl-prolyl-pyrrolidine, Quant. Struct.-Act. Relat. 16, 136-141 (1997).
26. Davies, E.K. and Murrall, N.W., How accurate does a force field need to be?, Computers Chem. 13, 149-156 (1989).
27. Halgren, T.A., Merck Molecular Force Field. 1. Basis, Form, Scope, Parametrization and Performance of MMFF94, J. Comp. Chem. 17, 490-519 (1996).
28. Cramer, R.D., Clark, R.D., Patterson, D.E. and Ferguson, A.M., Bioisosterism as a Molecular Diversity Descriptor. Steric Fields of Single 'Topomeric' Conformations, J. Med. Chem. 39, 3060-3069 (1996).